We are live on ! Find out more
New York State Common Retirement Fund

New York State Common Retirement Fund Portfolio holdings

AUM $79.3B
1-Year Est. Return 43.63%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+43.63%
3 Year Est. Return
+132.82%
5 Year Est. Return
+173.87%
10 Year Est. Return
+697.67%
AUM
$74.6B
AUM Growth
+$689M
Cap. Flow
-$992M
Cap. Flow %
-1.33%
Top 10 Hldgs %
32.53%
Holding
3,234
New
57
Increased
643
Reduced
1,082
Closed
59

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$40.8M
2
CME icon
CME Group
CME
+$28.7M
3
PRMB
Primo Brands
PRMB
+$25.4M
4
ACGL icon
Arch Capital
ACGL
+$19.3M
5
EVRG icon
Evergy
EVRG
+$18.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$81.9M
2
CNA icon
CNA Financial
CNA
+$55.4M
3
UNH icon
UnitedHealth
UNH
+$44.1M
4
AMD icon
Advanced Micro Devices
AMD
+$32.2M
5
SPOT icon
Spotify
SPOT
+$27.3M

Sector Composition

Rank Sector Weight
1 Technology 32.51%
2 Financials 13.47%
3 Consumer Discretionary 11.55%
4 Healthcare 10.78%
5 Communication Services 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRBT
3076
DELISTED
iRobot
IRBT
$6.44K ﹤0.01%
831
DLHC icon
3077
DLH Holdings
DLHC
$69.9M
$6.42K ﹤0.01%
800
VRCA icon
3078
Verrica Pharmaceuticals
VRCA
$91.7M
$6.35K ﹤0.01%
908
XBIT icon
3079
XBiotech
XBIT
$69.8M
$6.32K ﹤0.01%
1,600
SBDS
3080
DELISTED
Solo Brands Inc
SBDS
$6.13K ﹤0.01%
134
CDT icon
3081
CDT Equity Inc
CDT
$1.98M
0
FBLG icon
3082
FibroBiologics
FBLG
$6.59M
$5.8K ﹤0.01%
145
CIX icon
3083
Comp X International
CIX
$373M
$5.6K ﹤0.01%
214
EDIT icon
3084
Editas Medicine
EDIT
$438M
$5.58K ﹤0.01%
4,394
CDZI icon
3085
Cadiz
CDZI
$280M
$5.42K ﹤0.01%
1,042
ALTI icon
3086
AlTi Global
ALTI
$474M
$4.86K ﹤0.01%
1,101
OIS icon
3087
Oil States International
OIS
$528M
$4.72K ﹤0.01%
932
PRLD icon
3088
Prelude Therapeutics
PRLD
$386M
$4.62K ﹤0.01%
3,622
QRHC icon
3089
Quest Resource Holding
QRHC
$30.1M
$4.55K ﹤0.01%
700
CYD icon
3090
China Yuchai International
CYD
$1.75B
$4.26K ﹤0.01%
447
TLS icon
3091
Telos
TLS
$320M
$4.1K ﹤0.01%
1,200
MAPS
3092
DELISTED
WM TECHNOLOGY INC A
MAPS
$4K ﹤0.01%
2,900
ANRO icon
3093
Alto Neuroscience
ANRO
$1.08B
$3.81K ﹤0.01%
900
ACHV icon
3094
Achieve Life Sciences
ACHV
$685M
$3.52K ﹤0.01%
1,000
OTLK icon
3095
Outlook Therapeutics
OTLK
$209M
$3.44K ﹤0.01%
1,821
PHLT
3096
DELISTED
Performant Healthcare Inc
PHLT
$2.95K ﹤0.01%
978
ELEV
3097
DELISTED
Elevation Oncology
ELEV
$2.93K ﹤0.01%
5,200
GUTS icon
3098
Fractyl Health
GUTS
$111M
$2.88K ﹤0.01%
1,400
GBIO
3099
DELISTED
Generation Bio
GBIO
$2.84K ﹤0.01%
268
LFMD icon
3100
LifeMD
LFMD
$169M
$2.48K ﹤0.01%
500

Similar funds

New York State Common Retirement Fund's Q4 2024 Portfolio in Review

As of Q4 2024, New York State Common Retirement Fund held 3,234 positions worth $74.6B, up 0.93% from $73.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 3.6%. New York State Common Retirement Fund opened 57 new positions and exited 59, leaving the 3,234-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • New York State Common Retirement Fund's largest Q4 2024 buy was Primo Brands: 857,496 shares worth $26.4M.
  • New York State Common Retirement Fund added most to Boeing in Q4 2024, an estimated $40.8M increase.
  • New York State Common Retirement Fund's biggest Q4 2024 reduction was Apple, cutting an estimated $81.9M.
  • New York State Common Retirement Fund fully exited Primo Water Corporation in Q4 2024, selling an estimated $22.9M.
  • New York State Common Retirement Fund's ten largest holdings make up 33% of its $74.6B portfolio in Q4 2024.
  • New York State Common Retirement Fund opened 57 new positions and closed 59 in Q4 2024.
  • New York State Common Retirement Fund's portfolio value rose 0.93% quarter-over-quarter to $74.6B.

Based on New York State Common Retirement Fund's 13F filing for Q4 2024, filed 31 Jan 2025.